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Bacterial Blood-Stream Infections in Neutropenic 
Children with Hematologic/Oncologic Disorders 
at a Tertiary Care Centre in Saudi Arabia 
shift to GNB. These results upport he exclusion of 
vancomycin as part of the initial empiric therapy 
regime in febrile neutropenic patients. 
I. Bin-Hussain*, I. Kout[akis-Barron, M. Sa[im, M. A[ 
Hunaiti, S. A[-Jumaah, K. Siddiqui, A. Be[gumi, 
H. E[-So[h. King Faisal Specialist Hospital & 
Research Centre, Riyadh, Saudi Arabia 
Background: The aim of this study is to deter- 
mine predominant pathogens and their susceptibil- 
ity patterns in our pediatric patients with hema- 
tology onco[ogy disorders for proper selection of 
empiric antibiotic therapy. 
Nlethods: Retrospective chart review of chitdren 
with hematotogic/oncotogic d sorders and bac- 
teremia between January 1998 and December 
2005. 
Demographic data, undertying diseases, bacteria[ 
isotates, and antibiotic susceptibitity were re- 
viewed. 
Results: One thousand seventy nine bacteremia 
episodes were identified. The majority of isotates 
were GPC (52%) whereas Gram-negative bacteria 
(GNB) caused five hundred and fourteen episodes 
(48%). The most occurring GPC was coagu[ase nega- 
tive staphylococcus (32%), S. aureus (24%), S. pneu- 
moniae (15%), Enterococcus pp. (13%), and viri- 
dans streptococcus (10%). VRE was not isotated. 
For the Gram-negative isotates the most occur- 
ring were E. coli (23%), K. pneumoniae (19%), 
P. aeruginosa (18%), Enterobacter spp. (9%). The 
percentage of GNB isotates changed over the years 
accounting for 41%, 42%, 48%, 44%, 58%, 49%, 47%, 
and 47% for the years 1998, 1999, 2000, 2001, 
2002, 2003, 2004, and 2005, respectively. The 
sensitivity patterns for the hea[thcare associated 
blood stream infections indicated an increase in 
susceptibility for gentamicin from 60% to 64% to 
74% for 2003, 2004, 2005 respectively; Ceftazidime 
has shown an increase from 77% in 2003 to 85% in 
2004, then a decrease in 2005 to 69%. Cefepime 
sensitivity showed a slight increase from 77% in 
2003 to 81% in 2004 then a decrease to 76% in 2005. 
Tazocin indicates an increase from 58% in 2003, 
64% in 2004 and 80% in 2005. In addition, Amikacin 
shows an increase in sensitivity from 62.5% in 2003 
to 84% in 2004 and 85% in 2005. The changes in 
susceptibility patterns may be due to the change 
in the empirical therapy which occurred in June 
2003 from tazocin and gentamicin to cefepime and 
gentamicin. 
Conclusions: Our results concur with observations 
from other studies that in children with cancer GPC 
is a major causative pathogen of bacteremia, with 
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Evaluation of a LightCycler PCR Assay for the 
Detection of Invasive Aspergillosis in Pediatric 
Patients with Onco-hematological Diseases 
C. Stenghe[e, E. Franchin, E. Ca[ore, R. Mangane[[i, 
I. Cerbaro, R. Cusinato, G. Tride[[o, S. Cesaro*. 
Clinic o[ Pediatric Hematology Oncology, Via 
Giustiniani 3, 35128 Padova, Italy 
Background: Invasive Aspergi[[osis (IA) is associ- 
ated with high mortatity. Successfu[ outcome with 
treatment is [inked to earty diagnosis, but cutture 
and histotogy are [ate positive, whereas ctinicat- 
radiotogica[ signs do not arrow a certain diagnosis. 
Objective: To evatuate the rote of LightCycter PCR 
in the early diagnosis of IA in pediatric patients 
who underwent high doses of chemiotherapy or
hematopoietic stem cet[ transptantation; further- 
more, to evatuate sensitivity, specificity, PPV and 
NPV of LightCyc[er PCR compared to ELISA test for 
detection of gatactomannan tigen (GM test). 
Methods: 96 patients (mean age 10 years) at high 
risk for funga[ infection or with suspected fun- 
ga[ infection underwent clinical, radio[ogica[ and 
microbiological evaluations from January 2004 to 
October 2005. Microbiotogica[ evatuations inctuded 
GM test and LightCyc[er PCR test for funga[ DNA in 
brood. A tota[ of 579 brood samptes were corrected 
and examined by LightCyc[er PCR with FRET (Fluo- 
rescence Resonance Energy Transfer) technique, a
very specific method. 
Results: 9/96 (9.4%) patients developed IA, c[as- 
sifted as 5 proven, 3 probabte and 1 possibte 
(EORTC/MSG criteria). Sensitivity, specificity, PPV 
and NPV of LightCyc[er PCR were respectively 
87.5%, 56.32%, 15.55% and 98% when 1 positive 
sampte was sufficient o consider the test positive, 
and 62.5%, 86.2%, 29.41% and 96.15% when at [east 
2 positive samptes were required to consider the 
test positive. Sensitivity, specificity, PPV and NPV 
of GM test were respectively 50%, 96.2%, 57.14% 
and 95.06% when 1 positive sample was sufficient 
to consider the test positive, and 50%, 100%, 100% 
and 95.23% when at [east 2 positive samptes were 
required to consider the test positive. Considering 
a positive resutt from GM or LightCycter PCR test 
(and 2 consecutive positive samptes as criterium for 
positivity), the sensitivity, specificity, PPV and NPV 
were 75%, 85.18%, 33.33% and 97.18% respectively. 
Conclusions: LightCyc[er PCR had a good sensitivity 
and a high NPV: if negative, IA is unlikely; GM test 
